?

Goldstein Joseph L

Director
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK 1225474

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
6,548
Price per Share :
$703.43
Equivalence :
$4,606,059.64

Transaction History

  • A
    Form 4
    6,548 Shares After Transaction
    Value : $n/a
    $0.0
    01/02/25
  • Footnotes:
    #1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
  • M
    Form 4
    9,089 Shares After Transaction
    Value : $5,686,078.40
    $1,693,499.20
    01/23/24
  • S
    Form 4
    6,382 Shares After Transaction
    Value : $6,062,900.00
    Sold $2,571,650.00
    01/23/24